INJECTABLES / CHOOSING A TREATMENT
Xeomin vs. Botox: Differences, Cost and Which Lasts Longer

Offered Xeomin instead of Botox, or a lower price for it? Both are FDA-approved for the same upper-face lines and performed about the same for frown lines in head-to-head trials. Here is what actually differs: ingredients, units, price, duration and what to weigh before switching.
Compare the differences ↓Editorial details
THE QUICK ANSWER
Xeomin and Botox both soften expression lines, with results commonly lasting around three to four months. Direct frown-line trials found comparable improvement; neither is a proven winner for duration. Xeomin lacks the accessory proteins found in Botox but still contains other ingredients. On price, the gap is usually small: of 9 med spas in our November check that posted both, 8 charged the same or $1 to $4 a unit less for Xeomin. Choose around your provider’s plan, your previous response and the full visit price, rather than promises of a “cleaner” or resistance-proof treatment.
Xeomin labeling · Botox Cosmetic labeling · Direct comparison trial · Our price check
What is the difference between Xeomin and Botox?
They use different formulations of botulinum toxin type A to temporarily reduce muscle activity. This can soften lines made by frowning, raising your eyebrows or smiling. Neither adds volume like a filler, and neither guarantees that a deep crease visible at rest will disappear.
| Question | What to know |
|---|---|
| What is in each? | Xeomin: incobotulinumtoxinA, without accessory proteins. Botox: onabotulinumtoxinA, with accessory proteins. Both also contain human albumin; Xeomin has sucrose and Botox has sodium chloride. |
| Which areas are FDA-approved? | Both have adult cosmetic indications for frown lines, forehead lines and crow’s feet. Botox Cosmetic also has a platysma-band indication for the neck. |
| How soon and how long? | Expect the change to develop over days. In one direct trial, patients first noticed an effect at a median of three days with either product. Around three to four months is a useful duration expectation, not a personal forecast. |
| Are units interchangeable? | No. Both labels use 20 units for frown lines, but their units are product-specific. Matching numbers do not create a universal conversion rule. |
| Is Xeomin cheaper? | It can be at the same practice. Compare the complete treatment quote, including the proposed areas, product-specific dose and follow-up terms. |
Sources: Xeomin label, Botox Cosmetic label and Kane trial. If you are new to treatment, our Botox basics guide explains what these injections can and cannot change.
Is Xeomin as good as Botox, and does it work faster?
For frown lines, direct studies support comparable improvement at the main assessment. They do not establish one brand as consistently faster. The strongest comparison is a study that treats similar people, the same area and the same outcome, rather than two unrelated advertising claims.
A direct trial in 250 women
A 2015 randomized study compared 20 units of each product. At one month, independent photo reviewers found at least a one-grade improvement in 95.7% with Xeomin and 99.2% with Botox. The result met the study’s prespecified equivalence test.
Patients reported a median onset of three days with both. These figures describe response rates, not the percentage of wrinkles removed. Read the trial.
What that result does not settle
The trial involved women aged 18 to 50, mostly White, and one treatment cycle. Merz, Xeomin’s manufacturer, sponsored it. Comparable one-month improvement does not prove identical results for every face, area or future appointment.
A separate 503-person Chinese trial also found Xeomin met the study’s standard for comparable frown-line improvement at day 30. It was also Merz-funded. Read that trial.
One smaller three-product trial reported faster onset with Xeomin, but it used different doses from the standard labeled frown-line doses. That finding does not override the equal three-day onset in the 250-woman study. Plan your review with the practice instead of judging the brand after a day or two. Onset and duration study.
Does Xeomin last longer than Botox?
There is no dependable evidence that switching to Xeomin will give you an extra month. Xeomin’s label describes a typical effect lasting up to 12 to 16 weeks; Botox Cosmetic’s frown-line labeling describes approximately three to four months. Those label descriptions are not a head-to-head test.
The direct trials point in slightly different directions on duration, and neither settles it. In the 250-woman trial, results stayed similar for both products through four months, although the study formally tested equivalence only at one month. A smaller trial of 180 adults (60 each on Xeomin, Botox and Dysport) concluded that Xeomin lasted longer, but in its own analysis the product made only a small difference to duration that was not statistically significant. Sex mattered more: with all three products, results lasted longer in women than in men. That trial’s later checks were a month apart, which also limits claims about a difference of a few days. 250-woman trial; 180-adult trial.
If a longer-lasting result is your main reason to consider switching, our Daxxify vs. Botox comparison covers the brand whose head-to-head frown-line trial found about five extra weeks at the median, and what that costs.
For your own results, distinguish movement returning, the original crease returning and wanting another appointment. They can happen at different times. Record the same expression under similar lighting and compare with your starting photos. Our Botox duration guide explains how studies measure wear-off.
Is Xeomin “purer,” and can it prevent Botox resistance?
Xeomin has no accessory proteins, but “additive-free” is inaccurate. Its formulation still contains human albumin and sucrose. Botox Cosmetic contains the active toxin with accessory proteins, human albumin and sodium chloride. The difference in formulation is real; claims that it makes Xeomin universally safer, more natural or allergy-proof go further than the evidence. One practical difference you may hear about is storage: unopened Xeomin vials do not need refrigeration, while unopened Botox Cosmetic vials are kept refrigerated. That affects how a practice handles stock, not your result. Xeomin label; Botox Cosmetic label.
Antibodies are only one possible explanation for a poor result
The immune system can sometimes make antibodies that neutralize a toxin’s effect. However, a weak or short-lived cosmetic result does not diagnose that problem. The dose, placement, time since treatment and the kind of line being treated need reviewing first.
Xeomin’s label reports no newly developed neutralizing antibodies among 464 participants in its cosmetic frown-line trials. That is reassuring trial evidence, not a lifetime guarantee. An AbbVie-funded analysis of Botox studies found antibody formation uncommon; none of the 1,725 cosmetic participants were antibody-positive at study exit, although three frown-line participants had tested positive during follow-up. Different testing methods and study populations prevent a fair brand ranking from those separate numbers. Antibody analysis.
Switching brands is not a proven reset for established resistance. Both contain botulinum toxin type A. If a previously reliable result has changed, bring the prior treatment records to a qualified provider. Our Botox not working guide helps separate early assessment, treatment planning and possible loss of response.
Xeomin vs. Botox units: are the doses the same?
The labeled upper-face doses have matching numbers, but the units are not interchangeable. Each manufacturer uses its own potency assay. Your provider should plan and document the actual product, rather than translate an old invoice into a self-chosen dose.
| Area | What both labels specify |
|---|---|
| Frown lines / 11s | 20 units in total. |
| Forehead lines | 20 units in the forehead together with 20 units in the frown-line area: 40 units combined. |
| Crow’s feet | 12 units per side: 24 units in total. |
These are label reference doses, not a personal injection plan. Xeomin’s labeling allows all three upper-face areas together for a maximum total of 64 units. Botox Cosmetic also has a separate neck-band indication. “Lip flip,” masseter slimming and other uses you may hear about are outside these upper-face indications. Ask whether the proposed use is FDA-approved or off-label and what evidence supports it. Xeomin dosing and indications; Botox Cosmetic dosing and indications.
Both brands also have medical uses under their relevant labels. Approval or insurance coverage for a medical condition does not establish cosmetic coverage. This guide compares aesthetic facial treatment.
Is Xeomin cheaper than Botox?
Sometimes, but usually by a little. In our November check of 100 med spa locations, 9 posted regular prices for both brands. Four charged the same per unit, four charged $1 to $4 less for Xeomin and one charged $1 more. At the 20-unit frown-line dose, that is anywhere from $80 less to $20 more. Retail vial prices and prescription coupons do not represent a cosmetic appointment.
| Result | Price per unit, Botox / Xeomin |
|---|---|
| Xeomin lower: 4 practices | Cienega Medical, Santa Monica: $13 / $9 Glowme Med Spa, New York: $15 / $12 (single-visit rates) Allure Aesthetic Center, Alpharetta: $12 / $10 (20-unit minimum) Touch and Glow Med Spa, Glendale: $13 / $12 (nonmember rates) |
| Same price: 4 practices | Old Town Med Spa, Chicago: $12 for both Butterfly Medical Spa, Rockville: $15 for both at 19 units or fewer; its menu lists $11 for both at 20 or more, which its specials page calls a holiday rate COSMETICA Med Spa, Boca Raton: $9.99 for both (starting rate) Brows and Botox Med Spa, Evanston: $10 for both (starting rate) |
| Xeomin higher: 1 practice | The Beauty Bay Med Spa, Rockville: $10 / $11 (the Botox rate has a 20-unit minimum) |
For a 20-unit frown-line treatment, the four lower Xeomin prices save $80 (Cienega), $60 (Glowme), $40 (Allure) and $20 (Touch and Glow); at Beauty Bay, Xeomin costs $20 more. Both labels use 20 units for frown lines, so a 20-unit total is a fair same-practice comparison for that area; it does not make the units interchangeable for every area or dose. Across every location that posted each brand, the median was $11 a unit for Xeomin (10 locations) and $13.75 for Botox (32), but those are mostly different practices, so the pairs above are the better guide. These are dated examples, not an endorsement. See all 100 locations.
What a lower Xeomin price saves in a year
If both products last about the same for you, as the direct trials suggest on average, the per-visit difference simply repeats. Across these nine practices, three frown-line visits a year would cost anywhere from $240 less with Xeomin (Cienega) to $60 more (Beauty Bay), and exactly the same at four of them. If you switch, judge the result over a full cycle with matching photos before counting the saving: one extra visit a year would cancel most or all of it.
- Ask for the brand, areas, product-specific units and full visit total in writing.
- Check whether a review is included and when additional treatment would cost extra.
- Separate a one-time promotion or reward from the price you expect to pay again.
Our Botox cost guide compares posted prices for all five major brands at their labeled doses, along with treatment-area budgets and membership terms.
Should you switch from Botox to Xeomin?
A switch makes most sense when you can name the problem you are trying to solve. Lower cost, a provider’s preferred formulation and a disappointing previous result are different decisions. Keep them separate at the consultation.
Happy with Botox?
There is no evidence-based requirement to switch a treatment that is meeting your goals. Compare a Xeomin offer on total cost and the provider’s experience with your treatment area. Ask what they expect to stay the same and what they would change.
Unhappy with your last result?
Bring the product, date, areas, units and photos from the prior visit. Ask whether the issue was limited wrinkle improvement, unwanted brow position, short duration or a side effect. A different brand may be considered, but the plan may matter more than the name.
Do not add Xeomin between Botox appointments to chase a fading result. Xeomin’s label says repeat treatment should be no more frequent than every three months; Botox Cosmetic says dosing more often than every three months has not been clinically evaluated. Tell your provider about any botulinum toxin received during the previous four months. Xeomin timing and interactions; Botox timing and interactions.
A useful question is: “What would you change besides the brand, and how will we decide whether the result is better?” For your first treatment, ask about maintaining expression and the follow-up plan. See how to choose a treatment provider for consultation checks.
Is Xeomin safer than Botox?
Neither should be treated as the risk-free option. Both can cause injection-site effects and unwanted weakness near the treated area, including eyelid droop. Headache and other reactions are reported. Rates from separate trials cannot reliably establish which is safer for you. Both carry boxed warnings about toxin effects spreading beyond the injection area.
Do not receive either product if you have an infection at the planned injection site or have had an allergic reaction to any other botulinum toxin product. Xeomin is not a safe substitute to try after an allergic reaction to Botox. Tell the provider about muscle or nerve disorders, swallowing or breathing problems, prior surgery, all medicines, pregnancy plans and breastfeeding. Safety in pregnancy or breastfeeding is not established.
The consultation should distinguish allergy from bruising, headache or an unwanted cosmetic result. Our Botox eligibility guide and forehead side-effects guide explain the questions to raise. For first-day precautions after treatment, see our Botox aftercare guide, and follow the practice’s written instructions for the product you receive.
Xeomin vs. Botox FAQs
Is Xeomin FDA-approved?
Yes. Current U.S. labeling includes temporary improvement of moderate to severe frown lines, forehead lines and crow’s feet in adults. Older comparisons saying it is approved only for frown lines are out of date.
Does Xeomin look more natural than Botox?
Neither brand guarantees a more natural expression. Ask your provider what movement you want to keep, which muscles they plan to treat and how they will assess the result. The direct trials do not establish Xeomin as the more natural-looking product.
Does Xeomin last six months?
Do not budget on six months as the usual result. Its label describes a typical effect of up to 12 to 16 weeks, and direct comparative evidence does not establish a reliable duration advantage over Botox. Individual treatment experiences can vary.
Does Xeomin hurt less than Botox?
Both require injections. The evidence reviewed here does not establish a consistent pain advantage for either brand. Ask the practice how it manages discomfort and what to expect for the areas being treated.
Is Xeomin better for the forehead?
There is no strong basis here for naming it the better forehead treatment. Both labels specify forehead treatment together with the frown-line area. Much of the direct brand-comparison evidence concerns frown lines, so it should not be generalized to every forehead or brow concern.
Can I use Botox rewards to pay for Xeomin?
No. Botox Cosmetic rewards run through Allē, the Allergan Aesthetics program, while Xeomin has Merz Aesthetics’ separate Xperience+ program, so points earned with one brand do not pay for the other. Ask which programs the practice takes part in, and compare the price you would pay again once any one-time offer ends.
Sources and how we checked them
We checked current U.S. prescribing information, original comparative trials and our November 13, 2026 price check of 100 med spa locations. We distinguish label facts, study findings and price observations. Clinical review is pending. The cover is an editorial illustration, not a patient result or evidence of a treatment test.
View all 8 sources
- XEOMIN U.S. prescribing information and Medication Guide. Revised June 2026. Current cosmetic indications, doses, formulation, timing, antibody data and safety. Manufacturer labeling.
- BOTOX Cosmetic U.S. prescribing information and Medication Guide. Revised October 2024. Cosmetic indications including platysma bands, product-specific units, ingredients, timing and warnings. Manufacturer labeling.
- Kane et al., 2015: randomized equivalence study. 250 women; 20 units of each product, one-month response and patient-reported onset. Merz-sponsored; the prespecified equivalence margin was 15 percentage points. Four-month follow-up does not establish identical duration.
- Wu et al., 2023: randomized noninferiority study in Chinese adults. 503 participants; day-30 frown-line response. Merz-funded, with manufacturer affiliations and disclosed relationships.
- Rappl et al., 2013: onset and duration across three toxins. 180 participants; different doses and relatively widely spaced later assessments. The duration product effect was not statistically significant. Merz supported editorial assistance; an author disclosed speaker activity.
- Jankovic et al., 2023: neutralizing antibodies in onabotulinumtoxinA trials. Includes medical and cosmetic indications; we separate cosmetic results and antibodies during follow-up from those at exit. AbbVie funded and participated in the analysis. No Xeomin comparator.
- American Academy of Dermatology: botulinum toxin FAQs. Patient guidance on cosmetic effects, provider choice and realistic expectations.
- NuWays MD Botox price check, November 2026. 100 med spa locations in 10 metros; regular prices read twice on November 13, 2026. Nine locations posted regular prices for both Botox and Xeomin. Every location is listed on the method page, which also links the data file. Posted menu prices, not national averages or quotes for your treatment.